Westfälische Wilhelms-Universität (WWU) Münster

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European leukemia net risk classification (2023) Eckardt JN, Bill M, Rausch C, Metzeler K, Spiekermann K, Stasik S, Sauer T, et al. Journal article Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial (2023) Weller J, Schäfer N, Schaub C, Tzaridis T, Zeyen T, Schneider M, Potthoff AL, et al. Journal article The novel role of lymphatic vessels in the pathogenesis of ocular diseases (2023) Clahsen T, Hadrian K, Notara M, Schlereth SL, Howaldt A, Prokosch V, Volatier T, et al. Journal article, Review article IBEROAMERICAN REVIEWS RESEÑAS IBEROAMERICANAS (2023) Del Valle Lattanzio C, Jaeckel V, Cano EH, Rivero C, de la Paz PN, Calle JF, Salinas VC, et al. Journal article, Review article Screening and diagnostic breast MRI: how do they impact surgical treatment? Insights from the MIPA study (2023) Cozzi A, Di Leo G, Houssami N, Gilbert FJ, Helbich TH, Álvarez Benito M, Balleyguier C, et al. Journal article From atomistic systems to linearized continuum models for elastic materials with voids (2023) Friedrich M, Kreutz L, Zemas K Journal article Recommendations of the German Radiological Society's breast imaging working group regarding breast MRI Aktualisierung der Empfehlungen der AG Mammadiagnostik der Deutschen R ntgengesellschaft zur Durchfuhrung der Mamma-MRT (2023) Wenkel E, Wunderlich P, Fallenberg EM, Platz Batista Da Silva N, Preibsch H, Sauer S, Siegmann-Luz K, et al. Journal article Validating EEG source imaging using intracranial electrical stimulation (2022) Unnwongse K, Rampp S, Wehner T, Kowoll A, Parpaley Y, Von Lehe M, Lanfer B, et al. Journal article A diachronic perspective on lithic raw material procurement strategies and mobility: case studies from the Final Palaeolithic, Mesolithic and Neolithic in Central Europe (2022) Gehlen B, Affolter J, Schön W, Scharl S, Siegmund F, Fischer AL, Grunert M, et al. Journal article Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial (2022) Zeyen T, Potthoff AL, Nemeth R, Heiland DH, Burger MC, Steinbach JP, Hau P, et al. Journal article